Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Dyadic International Inc changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of DYAI: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders3639+3
Shares5.14M4.63M−514.5K (−10.0%)
Value$4.22M$4.14M−$70.3K (−1.7%)

New holders (6)

Institutions that held Dyadic International Inc at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to DYAI in Q2 2026
InstitutionSharesValue% of portfolio
Citadel Advisors LLC74,336$66.6K0.00%
XTX Topco Ltd46,665$41.8K0.00%
Jane Street Group, LLC41,217$36.9K0.00%
Ashton Thomas Securities, LLC36,155$32.4K0.00%
Tower Research Capital LLC (TRC)1,326$1.19K0.00%
UBS Group AG788$7060.00%

Sold out (3)

Institutions that held Dyadic International Inc at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of DYAI in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Susquehanna International Group, LLP25,925$21.3K
Two Sigma Securities, LLC21,612$17.7K
Black Diamond Financial, LLC19,331$15.9K